p.11 抽出テキスト

PRECISE-IVUS Plaque Regression with Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by Intravascular Ultrasound

PREVAIL Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with Atrial Fibrillation versus Long Term Warfarin Therapy PREVENT Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial PREVENT IV Project of Ex-vivo Vein Graft Engineering via Transfection IV PROactive Prospective Pioglitazone Clinical Trial in Macrovascular Events PROTECT AF Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation RAPCO Radial Artery Patency and Clinical Outcomes

RAVEL Randomised Study with the Sirolimus Eluting Bx Velocity Balloon Expandable Stent in the Treatment of Patients with de novo Native Coronary Artery Lesions ReACT Randomized Evaluation of Routine Followup Coronary Angiography after Percutaneous Coronary Intervention Trial REAL-CAD Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease

RE-DUAL PCI Randomized Evaluation of Dual Antithrombotic Therapy with Dabigatran versus Triple Therapy with Warfarin in Patients with Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention REDUCE Restenosis Reduction by Cutting Balloon Angioplasty Evaluation REDUCE-IT Reduction of Cardiovascular Events with EPA - Intervention Trial RIVAL Radial versus Femoral Access for Coronary Angiography and Intervention in Patients with Acute Coronary Syndromes

ROOBY Randomized On/Off Bypass SAVE-RITA Saphenous Vein versus Right Internal Thoracic Artery as a Y-composite trial SECURITY Second-Generation Drug-Eluting Stent Implantation Followed by Six- versus Twelve- Month Dual Antiplatelet Therapy SIRIUS Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions SMART Surgical Management of Arterial Revascularization Therapies SORT OUT IV Scandinavian Organization for Randomized Trials with Clinical Outcome IV

SPIRIT Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with De Novo Native Coronary Artery Lesions STARS Stent Antithrombotic Regimen Study Steno-2 Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria STICH Surgical Treatment for Ischemic Heart Failure SURVIVE Surgical Ventricular Reconstruction for Severe Ventricular Dysfunction SWISSI Swiss Interventional Study on Silent Ischemia Type SYNTAX Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery TVT Transcatheter Valve Therapy

WOEST What is the Optimal Antiplatelet and Anticoagulant Therapy in Patients with Oral Anticoagulation and Coronary Stenting

改訂にあたって

冠動脈血行再建術の治療法・術式選択や施行に関する有益かつ普遍的な診療指針を作成,推奨することを目的とした日本循環器学会の合同ガイドラインは,2000年に「冠動脈疾患におけるインターベンション治療の適応ガイドライン(冠動脈バイパス術の適応を含む)―待機的インターベンション」として初めて公表され,2006年には「虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン」が公表された.この領域の変化,進歩は急速であ

り,2009年には冠動脈血行再建術(経皮的冠動脈インターベンション:PCI,冠動脈バイパス術:CABG)の進歩に照らした改訂作業が開始された.その過程で,冠動脈血行再建術を体系的に再構築したガイドラインとすることが提案されたが,2011年に公表された改訂版では治療法の実際は各論として個別のガイドラインで詳述されるという方